Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

SBI Life Insurance - Q2FY21 First Cut - ICICI Securities

Posted On: 2020-10-26 06:33:30


(CMP - Rs. 779, MCap- Rs. 77894 crore)

SBI Life Insurance reported a healthy set of Q2FY21 numbers led by strong renewal premium accretion and investment income. Higher actuarial liability and elevated claims was offset by steady opex which led to reasonable PAT growth.

Q2FY21 Earnings Summary

- Premium growth was strong at 27.2% YoY to Rs. 12858 crore, led by higher traction in renewal (up 28% YoY) and single premium (up 71% YoY). Growth in renewal premium continued to remain healthy at ~28.1% YoY to Rs. 7150 crore, with renewal rate at 88% in Q2FY21. Despite Covid-19, new business premium growth was healthy at 27.4% YoY to Rs. 5940 crore led by strong accretion of protection and group premiums. In terms of NBP breakup, traction in individual business was muted at Rs. 2680 crore as against Rs. 2850 crore in Q2FY20, primarily led by decline in premium in unit linked products and non-par products. However, protection business (individual + group) reported strong growth at Rs. 620 crore in Q2FY21 vs Rs. 490 crore in Q2FY20. Proportion of total protection NBP to total NBP stood at ~10.4% in Q2FY21. Group savings products reported strong growth at Rs. 2650 crore, up 100.8% YoY

- AUM growth accelerated to Rs. 186360 crore. Shareholders and policyholders (excluding linked liabilities) assets witnessed healthy growth at ~21% and ~19% YoY, respectively. Assets held in lieu of linked products jumped ~22% YoY to Rs. 93476 crore. Recovery in equity market and decline in yields led to strong investment income at Rs. 5590 crore (up 113% YoY) in Q2FY21, supporting total revenue trajectory

- Healthy NBP accretion led to elevated commission expenses at Rs. 414 crore, up 1.5% YoY and 83.9% QoQ. However, higher commissions expenses were offset by steady opex, leading to overall opex (commission and opex related to insurance business) to come in at Rs. 1003 crore as against Rs. 1014 crore in Q2FY20. Subsequently, reported opex ratio came in at 4.6% in Q2FY21 vs 6% in Q2FY20

- Strong premium growth coupled with healthy investment income provided a boost to traction in top-line. However, higher actuarial liability and elevated claims (benefits paid) led to sequentially lower policyholder surplus at Rs. 410 crore (below our estimate). Lower surplus led to muted allocation to shareholders at Rs. 113 crore vs. Rs. 282 crore QoQ and Rs. 56 crore YoY. Subsequently, PAT came slightly lower than estimate at Rs. 300 crore but was strong on a YoY basis) Rs. 130 crore in Q2FY20)

- Solvency ratio was healthy at 2.45x as against 2.20x in Q2FY20

We would be shortly coming out with a detailed report.

Shares of SBI Life Insurance Company Ltd was last trading in BSE at Rs.778.75 as compared to the previous close of Rs. 770.3. The total number of shares traded during the day was 54462 in over 3346 trades.

The stock hit an intraday high of Rs. 784.95 and intraday low of 765.3. The net turnover during the day was Rs. 42317281.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com



Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Upgrade in target price of IDFC First Bank - Angel Broking

Laurus Labs stake acquisition in Richore Lifesciences - Angel Broking

Shares of Lakshmi Vilas Bank (LVB) suspended from trading - Angel Broking

Initiating Coverage on Sundram Fasteners - Fastening growth - HDFC Securities

Astral Poly Technik - Scalability to further improve with storage tanks foray - ICICI Securities

Vardhman Special Steel - Q2FY21 Company Update - ICICI Direct

Initiating Coverage - Advanced Enzyme Technologies - ICICI Direct

L&T - Secures Large Contract - Nov 25, 2020 - Angel Broking

Alembic Pharmaceuticals - Tentative Approval for JV - Angel Broking

Drug launch by Lupin - Tacrolimus Capsules - Angel Broking

Gujarat Gas - Nov 25, 2020 - Angel Broking

Metropolis Healthcare - Nov 25, 2020 - Angel Broking

NTPC - Showcase of strength & competitiveness - ICICI Securities

Telecom - Market Share TRACKER - Bharti is narrowing the gap on incremental market share vs RJio - ICICI Securities

Cochin Shipyard - Q2FY21 Result Update - ICICI Direct

Engineers India - Q2FY21 Result Update - ICICI Direct

Rupee - Nov 24, 2020 - Reliance Securities

FMCG Sector Update - Recovery unlocked; lower growth divergence - HDFC Securities

Engineers India - Consultancy segment outperformance - ICICI Securities

Engineers India - Q2 FY21 Result Update - YES SECURITIES

Motherson Sumi Systems - Company Update - Virtual Investor Conference - ICICI Direct

Mutual Fund Review - November, 2020 - ICICI Direct

Sadbhav Engineering - Q2FY21 Company Update - ICICI Direct

IRB Infrastructure - Q2FY21 Company Update - ICICI Direct

Vodafone Idea fund raising - Angel Broking

Rupee - Nov 23, 2020 - Reliance Securities

Crude Oil - Nov 23, 2020 - Reliance Securities

Q2FY21 Bank Result Quick Review - Angel Broking

Banks & NBFC's Sector Update Report - Yet another watershed moment? - HDFC Securities

Galaxy Surfactants - EBITDA/kg has an upside risk - ICICI Securities

Diagnostics - COVID-19 tests continue to trend higher - ICICI Securities

Banking & Financial Services - Sector Update - Nov 22, 2020 - ICICI Direct

Dalmia Bharat Sugar - Q2FY21 Company Update - ICICI Direct

Balkrishna Industries - Industry export growth momentum continues - ICICI Securities

Covid Recovery Pulse - Festive positivity continues in auto retails, E-way bill generation improves... - ICICI Direct

Quant Pick - Exide Industries - ICICI Direct

Shankara Building Products - Q2FY21 Company Update - ICICI Direct

Triveni Engineering - Q2FY21 Company Update - ICICI Direct

Initiating Coverage on Sudarshan Chemical - Leaping into the league of giants - HDFC Securities

Earnings Wrap Q2FY21: Earnings outperform, post Covid recovery picks up steam - ICICI Direct

Vodafone Idea Positive development beneficial for IDFC first bank - Angel Broking

Lakshmi Vilas Bank - Angel Broking

WIPRO Buyback record date announcement - Angel Broking

TCS buyback record date announcement - Angel Broking

Banks Sector Update - Collection efficiency - a positive surprise! - HDFC Securities

Quant Pick - Max Financial Services - ICICI Direct

Graphite India - Q2FY21 Result Update - ICICI Direct

Gladiator Stocks - Maruti Suzuki India - ICICI Direct

Exide Industries - Q2FY21 Result Update - ICICI Direct

Mishra Dhatu Nigam - Execution outlook remains strong - ICICI Securities



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019